Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- ChecktodayChange DetectedThe page shows a revision update to v3.5.4, replacing the previous v3.5.3. This reflects a small metadata/versioning update rather than a substantive change to content or functionality.SummaryDifference0.0%

- Check7 days agoChange DetectedThe study's recruitment locations expanded to 44 sites (up from 41), with new site listings and updated contacts for Utah, Houston, and Colorado. A prior 41-location count and the investigator Debabrata Bandyopadhyay, MD were removed.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedUpdates the page/version footer from **Revision: v3.5.2** to **Revision: v3.5.3**, with no change to the study content or record details.SummaryDifference0.1%

- Check29 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved the text 'Interstitial lung disease 2' from the page. It appears to be a non-critical label and its removal does not affect the study details or enrollment information.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.